JPS627A - Skin external agent containing incorporated urea - Google Patents
Skin external agent containing incorporated ureaInfo
- Publication number
- JPS627A JPS627A JP2226086A JP2226086A JPS627A JP S627 A JPS627 A JP S627A JP 2226086 A JP2226086 A JP 2226086A JP 2226086 A JP2226086 A JP 2226086A JP S627 A JPS627 A JP S627A
- Authority
- JP
- Japan
- Prior art keywords
- urea
- skin external
- external agent
- skin
- agent containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、角化症治療剤などとして用いられている尿素
製剤に、分子内に3ヶ以上の水酸基を有する多価アルコ
ールを配合して、尿素の保湿作用を相乗的に高め、かつ
尿素の副作用の1つである皮膚に対するち(ちく感やひ
りっきを抑えた尿素配合皮膚外用剤に関するものである
。[Detailed Description of the Invention] [Industrial Application Field] The present invention is a urea preparation used as a keratosis treatment, etc., containing a polyhydric alcohol having three or more hydroxyl groups in the molecule. This topic relates to a urea-containing external skin preparation that synergistically enhances the moisturizing effect of urea and suppresses one of the side effects of urea, tingling and irritation, on the skin.
[従来の技術]
尿素は生体内に存在し、蛋白のポリペプチドに変化を与
える結果、その可溶性を増大させ、抗菌作用、蛋白融解
変質作用、水和現象、すなわち、水分保持能力の亢進作
用など皮膚化学的に重要な薬理作用があり、魚鱗彦、進
行性指掌角度症、老人性乾皮症や手指の荒れ、ひじ、ひ
ざ、かかと、課の角化症の治療薬として、一般に10〜
20重量%の濃度で用いられている。[Prior art] Urea exists in living organisms, and as a result of changing protein polypeptides, it increases its solubility, and has antibacterial effects, proteolytic denaturing effects, hydration phenomenon, that is, enhancement of water retention ability, etc. It has an important pharmacological effect on skin chemistry, and is generally used as a treatment for ichthyosis, progressive palmar angle syndrome, senile xeroderma, rough fingers, and keratosis of the elbows, knees, heels, and sections.
It is used at a concentration of 20% by weight.
[発明が解決しようとする問題点]
しかし、尿素はその副作用の1つに、一過性ではあるが
、皮膚に対するちくちく感やひりつきを持っている。[Problems to be Solved by the Invention] However, one of the side effects of urea is a tingling or stinging sensation on the skin, although it is temporary.
尿素は水の共存下で酸、アルカリ、熱などにより容易に
加水分解を受けてアンモニアを発生することが知られて
おり、尿素の安定配合に関しては多くの検討がなされて
いるが、尿素の保湿作用を元通させることや、尿素の皮
膚に対するちくちく感およびひりつきを抑制する方法に
ついては現在まで殆ど検討されていない。It is known that urea is easily hydrolyzed by acids, alkalis, heat, etc. in the coexistence of water and generates ammonia. To date, little research has been done on restoring the effect or suppressing the prickling and stinging sensation of urea on the skin.
[問題点を解決するための手段]
本発明者はこれらの状況を鑑みて、鋭意研究した結果、
尿素製剤中に、分子内に3ヶ以上の水酸基を有する多価
アルコールを添加することによって尿素のみあるいは該
多価アルコールのみを添加したものより保湿効果を相乗
的に高め、しかも尿素特有のちくちく感やひりつきを少
なくできることを見い出し、本発明を完成させたもので
ある。[Means for Solving the Problems] In view of these circumstances, the inventor has conducted extensive research and has found that:
By adding a polyhydric alcohol having three or more hydroxyl groups in the molecule to a urea preparation, the moisturizing effect is synergistically enhanced compared to the addition of only urea or only the polyhydric alcohol, and the tingling sensation unique to urea is achieved. The present invention was completed based on the discovery that the tingling and stinging could be reduced.
すなわち、本発明は、尿素を主有効成分としてなる皮膚
外用剤において、分子内に3ヶ以上の水酸基を有する多
価アルコールの1種又は2種以上を配合することを特徴
とする皮膚外用剤である。That is, the present invention provides an external skin preparation containing urea as a main active ingredient, which is characterized by containing one or more polyhydric alcohols having three or more hydroxyl groups in the molecule. be.
尿素の配合量は一般的には皮膚外用剤全量中の2〜30
重量%、好ましくは5〜20重量%である。The amount of urea added is generally 2 to 30% of the total amount of the skin external preparation.
% by weight, preferably from 5 to 20% by weight.
2重量%未満では尿素の保湿作用があまり期待できず、
また30重量%を越える配合は尿素の結晶析出が起こり
やすい上にひりつき、ちくちく感が抑制できなくなるの
で好ましくない。If it is less than 2% by weight, the moisturizing effect of urea cannot be expected much;
Moreover, a blend exceeding 30% by weight is not preferable because urea crystals tend to precipitate and stinging and tingling sensations cannot be suppressed.
分子内に3ヶ以上の水酸基を有する多価アルコールとし
ては、グリセリン、ジグリセリン、トリグリセリン、テ
トラグリセリン等のポリグリセリン、スレイトール、エ
リスリトール、フラクトース、キシリトール、ソルビト
ール、マルトトリオース、グルコース、マルチドース、
マルチトール等であり、これらのうち1種又は2種以上
が用いられる。Examples of polyhydric alcohols having three or more hydroxyl groups in the molecule include polyglycerin such as glycerin, diglycerin, triglycerin, and tetraglycerin, threitol, erythritol, fructose, xylitol, sorbitol, maltotriose, glucose, multidose,
maltitol, etc., and one or more of these may be used.
配合量は5〜90重量%、好ましくは10〜50重量%
、さらに好ましくは10〜30重量%である。The blending amount is 5 to 90% by weight, preferably 10 to 50% by weight.
, more preferably 10 to 30% by weight.
上記の必須成分に加えて、油性成分を加えるとより好ま
しい結果が得られる。油性成分は一般に用いられている
医薬用、化粧用の油性成分であり、とくにアジピン酸ジ
イソプロピル、セバシン酸ジエチル等の分岐飽和脂肪族
アルコールと飽和脂肪族2塩基酸またはリンゴ酸、酒石
酸、クエン酸とのエステル油やシリコン油が好ましい。More favorable results can be obtained by adding an oily component in addition to the above essential components. Oily ingredients are commonly used medicinal and cosmetic oily ingredients, and in particular branched saturated aliphatic alcohols such as diisopropyl adipate and diethyl sebacate, saturated aliphatic dibasic acids, or malic acid, tartaric acid, and citric acid. Ester oils and silicone oils are preferred.
これらの中でも低粘度のものが望ましい。Among these, those with low viscosity are desirable.
油性成分は、本発明の皮膚外用剤の使用感触、主にべた
つき感を改善する効果も有する。The oily component also has the effect of improving the feel of the external skin preparation of the present invention, mainly the sticky feeling.
配合量は10〜60重量%、好ましくは15〜40重量
%である。The blending amount is 10 to 60% by weight, preferably 15 to 40% by weight.
本発明の皮膚外用剤には、この他に必要に応じて薬剤、
防腐剤、酸化防止剤、増粘剤、着色剤、香料、尿素の安
定剤としてアンモニウム塩や緩衝液、界面活性剤、他の
保湿剤等を配合してもよい。In addition to this, the skin external preparation of the present invention may include drugs,
Preservatives, antioxidants, thickeners, colorants, fragrances, ammonium salts as urea stabilizers, buffers, surfactants, other humectants, etc. may be added.
[発明の効果]
本発明の皮膚外用剤は、尿素および多価アルコールの保
湿作用が相乗的に先進され、かつ尿素特有の皮膚に対す
るちくちく感、ひりつきが改善された皮膚外用剤で、薬
用製剤分野においては勿論のこと化粧品分野においても
応用できる。[Effects of the Invention] The external skin preparation of the present invention is a skin external preparation in which the moisturizing effects of urea and polyhydric alcohol have been synergistically advanced, and the prickling and stinging sensation peculiar to urea on the skin has been improved. It can be applied not only in the field of cosmetics but also in the field of cosmetics.
[実施例]
次に本発明の尿素と多価アルコールとの併用による保湿
亢進作用およびち(ちく感、ひりつきの低減について実
施例にて詳細に説明する。[Example] Next, the moisturizing enhancement effect and the reduction of stinging sensation and stinging sensation due to the combined use of urea and polyhydric alcohol of the present invention will be explained in detail in Examples.
(以下余白)
処 方 実施例1比較例1比較例2ステアリ
ン酸 3.0 3.0 3.0ワセリン
4.0 4.0 4.0イソプロ
ピルミリステ 2.0 2.0 2.0−ト
アジピン酸イソプロピ 5.0 5.0 5.0ル
ジメチルポリシロキサ 2.0 2.0 2.0ン
(6cs)
セトステアリルアルコ 4.5 4.5 4.5
−ル
グリセリルモノステア 2.5 2.5 2.5
レート
ブチルパラベン 0.1 0.1 0.1
エチルパラベン 0.1 0.1 0.1
プロピレングリコール 5.0 10.0 5.0
グリセリン 10.0 − −ソルビト
ール 10.0 − 20.01.3ブ
チレングリコ −20,0−
一ル
尿素 10.0 10.0 −
グリシン 1.0 1.0 1.0K
OHO,10,10,1
クエン酸緩衝液 残余 残余 残余実施例1
、比較例1および比較例2のクリーム製剤を製造し、健
常人男性パネルの前腕層側部の角層水分量を、コンダク
タンス測定により比較検討した。(Left below) Prescription Example 1 Comparative Example 1 Comparative Example 2 Stearic acid 3.0 3.0 3.0 Vaseline 4.0 4.0 4.0 Isopropyl myriste 2.0 2.0 2.0-Toadipine Isopropyl acid 5.0 5.0 5.0 Dimethyl polysiloxane 2.0 2.0 2.0 (6 cs) Cetostearyl alco 4.5 4.5 4.5
-Luglyceryl monostear 2.5 2.5 2.5
Butylparaben 0.1 0.1 0.1
Ethylparaben 0.1 0.1 0.1
Propylene glycol 5.0 10.0 5.0
Glycerin 10.0 - - Sorbitol 10.0 - 20.01.3 Butylene glyco -20,0- Monolurea 10.0 10.0 -
Glycine 1.0 1.0 1.0K
OHO, 10, 10, 1 Citrate buffer Residual Residual Example 1
Cream formulations of Comparative Example 1 and Comparative Example 2 were manufactured, and the moisture content of the stratum corneum on the side of the forearm layer of a panel of healthy male subjects was compared and examined by conductance measurement.
結果を表−1に示す。The results are shown in Table-1.
コンダクタンス値は、n=5の平均値を示すもので塗布
後5時間後の値である。測定は25℃、50%RHでl
B5−355 (IBS社製)により測定したもので
、値が大きい程、角質水分量が多いことを示す。The conductance value shows the average value of n=5, and is the value 5 hours after application. Measurements were carried out at 25°C and 50% RH.
B5-355 (manufactured by IBS), and the larger the value, the greater the stratum corneum water content.
(以下余白)
表−1
処 方 測 定 時 コンダクタンス実施例1
塗布前 10.0μΩ塗布後 120.
0
比較例1 塗布前 9.0
塗布後 20.0
比較例2 塗布前 12.0塗布後
47.0
コントロ 塗布前 9.0
−ル 塗布後 10.0また、尿素のひ
りつき感に関して、日常化粧品に敏感な女性パネル6名
に使用テストを行い、多価アルコールのちくちく感、ひ
りつきなどの抑制効果について検討した。(Leaving space below) Table-1 Prescription Measurement Conductance Example 1
Before application 10.0μΩ After application 120.
0 Comparative Example 1 Before application 9.0 After application 20.0 Comparative Example 2 Before application 12.0 After application
47.0 Control Before application 9.0 - After application 10.0 Also, regarding the stinging feeling of urea, we conducted a usage test on 6 female panels who are sensitive to everyday cosmetics, and found that polyhydric alcohol's tingling, stinging, etc. We investigated the suppressive effect of
結果を表−2に示す。The results are shown in Table-2.
使用テストの部位は手の甲を用いた。使用テストは原則
として1日2回とし、゛3日間行い、延べ36回のテス
ト結果で判定は下記の判定項目および評価で行った。The back of the hand was used as the test site. The use test was carried out twice a day in principle for 3 days, and the results of a total of 36 tests were judged based on the following judgment items and evaluation.
表−2は、延べ36回のテストで1以上の評点をつけた
人の割合を示すものである。Table 2 shows the percentage of people who gave a score of 1 or higher in a total of 36 tests.
−判定項目−
1、かゆみ
2、ひりつき
3、しみる
4、ちくちく感
5、いたみ
一評価法一
なし ・・・0点
ややあり・・・1点
やや強い・・・2点
強い ・・・3点
表−2
かゆみ ひり しみる ちく いたみつき
ちく感
(%)
実施例1 5.6 5.6 5.6 8.3
0比較例1 13.9 16.7 5.6 2
2.2 0比較例2 0 0 5.6
0 0さらに実施例を示す。- Judgment Items - 1. Itching 2, Stinging 3, Stinging 4, Prickling 5, Soreness - Evaluation method - None...0 points Slightly present...1 points Slightly strong...2 points Strong... 3-point table-2 Itching Stinging Stinging Itching
Tingling feeling (%) Example 1 5.6 5.6 5.6 8.3
0 Comparative Example 1 13.9 16.7 5.6 2
2.2 0 Comparative Example 2 0 0 5.6
0 0 Further examples will be shown.
実施例2
ステアリン酸 2重量%スクワ
ラン 5セトステアリルアル
コール 4グリセリン七ノ脂肪酸エステル
3POEソルビタンモノステアレート 1エチ
ルパラベン 0.1香料
0.2尿素
10グリセリン
201,3ブチレングリコール 10ヒア
ルロン酸ナトリウム 0.2エデト酸2
ナトリウム 0.05炭酸アンモニウ
ム 0.1精製水
残余常法に従って尿素配合クリーム製剤を
製造した。Example 2 Stearic acid 2% by weight squalane 5 cetostearyl alcohol 4 glycerin heptanofatty acid ester
3 POE Sorbitan Monostearate 1 Ethylparaben 0.1 Fragrance
0.2 urea
10 glycerin
201,3 Butylene glycol 10 Sodium hyaluronate 0.2 Edetic acid 2
Sodium 0.05 Ammonium carbonate 0.1 Purified water
A urea-containing cream preparation was produced according to a conventional method.
実施例2は皮膚に対する保湿効果に優れ、尿素の持つ肌
に対するちくちく感やひりつきのないクリームであった
。Example 2 was a cream that had an excellent moisturizing effect on the skin and did not have the prickly or stinging feeling that urea has on the skin.
実施例3
尿素 25プロピレング
リコール 5グリセリン
45タウリン 5
精製水 20(製造方法
)
常法に従って尿素配合ローションを製造した。Example 3 Urea 25 Propylene Glycol 5 Glycerin
45 Taurine 5
Purified water 20 (Production method) A urea-containing lotion was produced according to a conventional method.
実施例3は皮膚に対する保湿効果に優れ、尿素の持つ肌
に対するちくちく感やひりつきのないローションであっ
た。Example 3 was a lotion that had an excellent moisturizing effect on the skin and did not have the prickly or stinging feeling that urea has on the skin.
実施例4
尿素 5プロピレング
リコール 10グリセリン
80タウリン 1
精製水 4(製造方法)
常法に従って尿素配合ローションを製造した。Example 4 Urea 5 Propylene glycol 10 Glycerin
80 Taurine 1
Purified water 4 (Production method) A urea-containing lotion was produced according to a conventional method.
実施例4は皮膚に対する保湿効果に優れ、尿素の持つ肌
に対するちくちく感やひりつきのないローションであっ
た。Example 4 was a lotion that had an excellent moisturizing effect on the skin and did not have the prickly or stinging feeling that urea has on the skin.
Claims (1)
、分子内に3ケ以上の水酸基を有する多価アルコールの
1種又は2種以上を配合することを特徴とする皮膚外用
剤。(1) An external skin preparation containing urea as a main active ingredient, which contains one or more polyhydric alcohols having three or more hydroxyl groups in the molecule.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60-42236 | 1985-03-04 | ||
JP4223685 | 1985-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS627A true JPS627A (en) | 1987-01-06 |
Family
ID=12630390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2226086A Pending JPS627A (en) | 1985-03-04 | 1986-02-04 | Skin external agent containing incorporated urea |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS627A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03291207A (en) * | 1990-04-06 | 1991-12-20 | Kanebo Ltd | Dermatic agent for external use |
JPH04124118A (en) * | 1990-09-14 | 1992-04-24 | Shiseido Co Ltd | Skin external preparation |
WO1995001158A1 (en) * | 1993-07-01 | 1995-01-12 | Kuehnl Petzoldt Christa | Shower lotions for dry skin treatment and care |
WO1995015149A1 (en) * | 1993-12-02 | 1995-06-08 | Sederma S.A. | Novel cosmetic compositions containing simple polyols |
JP2002167328A (en) * | 2000-11-29 | 2002-06-11 | Toyo Aerosol Ind Co Ltd | Composition and aerosol composition for external skin preparation |
JP2006524199A (en) * | 2003-04-24 | 2006-10-26 | ロレアル | Cosmetic peeling method |
JP2007269692A (en) * | 2006-03-31 | 2007-10-18 | Pola Chem Ind Inc | Cosmetic material for softening skin |
JP2008069179A (en) * | 2007-12-03 | 2008-03-27 | Rohto Pharmaceut Co Ltd | Emulsion composition |
WO2015080011A1 (en) * | 2013-11-29 | 2015-06-04 | 花王株式会社 | External preparation for skin |
CN112823777A (en) * | 2019-11-21 | 2021-05-21 | 上海家化联合股份有限公司 | Composition containing urea |
CN112823775A (en) * | 2019-11-21 | 2021-05-21 | 上海家化联合股份有限公司 | Composition containing urea |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5148441A (en) * | 1974-10-22 | 1976-04-26 | Kowa Co | HIFUSHORISOSEIBUTSUNO ANTEIKAHOHO |
JPS51112530A (en) * | 1975-03-25 | 1976-10-05 | Mitsuaki Ishimoto | Compositions for the toiletry |
JPS5636412A (en) * | 1979-08-30 | 1981-04-09 | Herschler R J | Methylsulfonylmethaneecontaining composition* its use and purification |
JPS57150608A (en) * | 1981-02-02 | 1982-09-17 | Oreal | Wetting agent composition |
JPS5869806A (en) * | 1981-10-20 | 1983-04-26 | Mochida Pharmaceut Co Ltd | Cosmetic lotion containing stable collagen |
JPS58183608A (en) * | 1982-04-19 | 1983-10-26 | Shiseido Co Ltd | Transparent cosmetic |
JPS59193812A (en) * | 1983-04-15 | 1984-11-02 | Nippon Saafuakutanto Kogyo Kk | Powdery cosmetic |
-
1986
- 1986-02-04 JP JP2226086A patent/JPS627A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5148441A (en) * | 1974-10-22 | 1976-04-26 | Kowa Co | HIFUSHORISOSEIBUTSUNO ANTEIKAHOHO |
JPS51112530A (en) * | 1975-03-25 | 1976-10-05 | Mitsuaki Ishimoto | Compositions for the toiletry |
JPS5636412A (en) * | 1979-08-30 | 1981-04-09 | Herschler R J | Methylsulfonylmethaneecontaining composition* its use and purification |
JPS57150608A (en) * | 1981-02-02 | 1982-09-17 | Oreal | Wetting agent composition |
JPS5869806A (en) * | 1981-10-20 | 1983-04-26 | Mochida Pharmaceut Co Ltd | Cosmetic lotion containing stable collagen |
JPS58183608A (en) * | 1982-04-19 | 1983-10-26 | Shiseido Co Ltd | Transparent cosmetic |
JPS59193812A (en) * | 1983-04-15 | 1984-11-02 | Nippon Saafuakutanto Kogyo Kk | Powdery cosmetic |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03291207A (en) * | 1990-04-06 | 1991-12-20 | Kanebo Ltd | Dermatic agent for external use |
JPH04124118A (en) * | 1990-09-14 | 1992-04-24 | Shiseido Co Ltd | Skin external preparation |
WO1995001158A1 (en) * | 1993-07-01 | 1995-01-12 | Kuehnl Petzoldt Christa | Shower lotions for dry skin treatment and care |
WO1995015149A1 (en) * | 1993-12-02 | 1995-06-08 | Sederma S.A. | Novel cosmetic compositions containing simple polyols |
FR2713086A1 (en) * | 1993-12-02 | 1995-06-09 | Sederma Sa | New cosmetic compositions containing simple polyols. |
JP2002167328A (en) * | 2000-11-29 | 2002-06-11 | Toyo Aerosol Ind Co Ltd | Composition and aerosol composition for external skin preparation |
JP2006524199A (en) * | 2003-04-24 | 2006-10-26 | ロレアル | Cosmetic peeling method |
JP2007269692A (en) * | 2006-03-31 | 2007-10-18 | Pola Chem Ind Inc | Cosmetic material for softening skin |
JP2008069179A (en) * | 2007-12-03 | 2008-03-27 | Rohto Pharmaceut Co Ltd | Emulsion composition |
WO2015080011A1 (en) * | 2013-11-29 | 2015-06-04 | 花王株式会社 | External preparation for skin |
CN112823777A (en) * | 2019-11-21 | 2021-05-21 | 上海家化联合股份有限公司 | Composition containing urea |
CN112823775A (en) * | 2019-11-21 | 2021-05-21 | 上海家化联合股份有限公司 | Composition containing urea |
CN112823775B (en) * | 2019-11-21 | 2024-03-19 | 上海家化联合股份有限公司 | Urea-containing composition |
CN112823777B (en) * | 2019-11-21 | 2024-04-26 | 上海家化联合股份有限公司 | Urea-containing composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3487633B2 (en) | Skin disease treatment emulsion | |
US20060088497A1 (en) | Topical skin care composition | |
CN110621346A (en) | Skin barrier composition | |
JPS627A (en) | Skin external agent containing incorporated urea | |
JPS59134706A (en) | Cosmetic | |
JPH08291057A (en) | Cataplasm | |
JP4039567B2 (en) | Aqueous cosmetics | |
JPH09291013A (en) | Skin cosmetic material | |
JPH04360820A (en) | Cosmetic | |
JP3798927B2 (en) | Blood circulation promoting topical skin preparation | |
JP3479048B2 (en) | Cosmetics and non-woven fabric impregnated cosmetics | |
JPH0521081B2 (en) | ||
JPS61227515A (en) | External preparation for skin | |
JP2001278768A (en) | Skin care preparation | |
JP6484547B2 (en) | Pruritus improving agent | |
CN110496065A (en) | Moisturizing composition | |
JPH10279427A (en) | Moisture-retaining cosmetic material composition | |
JPS61210013A (en) | External preparation for skin | |
JP3710564B2 (en) | Transdermal absorption-promoting skin external preparation | |
JPH08165244A (en) | Dermatosis therapeutic agent | |
JPH09124453A (en) | Dermal preparation for external use | |
JPH04290808A (en) | Cosmetic | |
JPH08283138A (en) | Skin cosmetic | |
JPH11292751A (en) | Skin cosmetic | |
JP4440556B2 (en) | Transdermal absorption enhancer and transdermal absorption preparation |